|
[1]ZHUANG H.Current status and goals of hepatitis B prevention and treatment[J].Chin J Intern Med,2008,47(10):793-795.(in Chinese)庄辉.我国乙型肝炎防治现状及目标[J].中华内科杂志,2008,47(10):793-795.
|
|
[2] ZHANG RL,LU LG.Current situation and future prospect of cholangiopathy[J].J Clin Hepatol,2011,27(9):903-905.(in Chinese)张汝玲,陆伦根.胆道疾病的研究现状[J].临床肝胆病杂志,2011,27(9):903-905.
|
|
[3]GUO QY,SHI Y.Applications and advances of magnetic resonance imaging in diagnosing liver disease[J].Chin J Magn Reson Imaging,2014,5(s1):10-14.(in Chinese)郭启勇,石喻.磁共振成像在肝病的应用及进展[J].磁共振成像,2014,5(s1):10-14.
|
|
[4]CHEN C,WANG B,SHI D,et al.Initial study of biexponential model of intravoxel incoherent motion magnetic resonance imaging in evaluation of the liver fibrosis[J].Chin Med J(Engl),2014,127(17):3082-3087.
|
|
[5]WOO S,LEE JM,YOON JH,et al.Intravoxel incoherent motion diffusion-weighted MR imaging of hepatocellular carcinoma:correlation with enhancement degree and histologic grade[J].Radiology,2014,270(3):758-767.
|
|
[6]PARK YS,LEE CH,KIM JH,et al.Using intravoxel incoherent motion(IVIM)MR imaging to predict lipiodol uptake in patients with hepatocellular carcinoma following transcatheter arterial chemoembolization:a preliminary result[J].Magn Reson Imaging,2014,32(6):638-646.
|
|
[7]KIM JH,JOO I,KIM TY,et al.Diffusion-related MRI parameters for assessing early treatment response of liver metastases to cytotoxic therapy in colorectal cancer[J].AJR,2016,207(3):w26-w32.
|
|
[8]WU Q,FU Q,ZHAO H,et al.Application of intravoxel incoherent motion diffusion-weighted imaging in liver diseases[J].J Clin Hepatol,2015,31(10):1744-1746.(in Chinese)吴琼,付旷,赵荟,等.体素内不相干运动扩散加权成像在肝脏疾病诊疗中的应用[J].临床肝胆病杂志,2015,31(10):1744-1746.
|
|
[9]STRUYFS H,van HECKE W,VERAART J,et al.Diffusion kurtosis imaging:a possible MRI biomarker for AD diagnosis?[J].J Alzheimers Dis,2015,48(4):937-948.
|
|
[10]ZHANG Y,GAO Y,ZHOU M,et al.A diffusional kurtosis imaging study of idiopathic generalized epilepsy with unilateral interictal epileptiform discharges in children[J].J Neuroradiol,2016,43(5):339-345.
|
|
[11]ROSENKRANTZ AB,SIGMUND EE,WINNICK A,et al.Assessment of hepatocellular carcinoma using apparent diffusion coefficient and diffusion kurtosis indices:preliminary experience in fresh liver explants[J].Magn Reson Imaging,2012,30(10):1534-1540.
|
|
[12]GOSHIMA S,KANEMATSU M,NODA Y.Diffusion kurtosis imaging to assess response to treatment in hypervascular hepatocellular carcinoma[J].AJR,2015,204(5):543-549.
|
|
[13]XU ML,XING CH,CHEN HW,et al.Application value of DKI in grading of extrahepatic cholangiocarcinoma[J].Chin J Magn Reson Imaging,2016,7(1):34-39.(in Chinese)徐蒙莱,邢春华,陈宏伟,等.DKI技术在肝外胆管癌分级中的应用价值[J].磁共振成像,2016,7(1):34-39.
|
|
[14]CHEN LH,LIU AL.Applications of diffusional kurtosis tensor imaging in abdomen[J].Chin J Med Imaging Technol,2015,32(4):631-633.(in Chinese)陈丽华,刘爱连.磁共振弥散峰度成像在腹部的应用[J].中国医学影像技术,2015,32(4):631-633.
|
|
[15]VENKATESH SK,YIN M,EHMAN RL.Magnetic resonance elastography of liver:clinical applications[J].J Comput Assist Tomogr,2013,37(6):887-896.
|
|
[16]XANTHAKOS SA,PODBERESKY DJ,SERAI SD,et al.Use of magnetic resonance elastography to assess hepatic fibrosis in children with chronic liver disease[J].J Pediatr,2014,164(1):186-188.
|
|
[17]DULAI PS,SIRLIN CB,LOOMBA R.MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH:Clinical trials to clinical practice[J].J Hepatol,2016,65(5):1006-1016.
|
|
[18]VENKATESH SK,YIN M,GLOCKNER JF,et al.MR elastography of liver tumors:preliminary results[J].AJR,2008,190(6):1534-1540.
|
|
[19]SOUCHON R,SALOMIR R,BEUF O,et al.Transient MR elastography(t-MRE)using ultrasound radiation force:theory,safety,and initial experiments in vitro[J].Magn Reson Med,2008,60(4):871-881.
|
|
[20]YUAN F,SONG B.The progress and prospect of imaging examination for liver diseases[J].Sichuan Med J,2015,36(5):592-595.(in Chinese)袁放,宋彬.肝脏疾病的影像学检查技术进展与展望[J].四川医学,2015,36(5):592-595.
|
|
[21]LEE SS,PARK SH.Radiologic evaluation of nonalcoholic fatty liver disease[J].World J Gastroenterol,2014,20(23):7392-7402.
|
|
[22]WU B,HAN W,LI Z,et al.Reproducibility of intra-and interscanner measurements of liver fat using complex confounder-corrected chemical shift encoded MRI at 3.0 tesla[J].Sci Rep,2016,6:19339.
|
|
[23]LI Z,SUN J,CHEN L,et al.Assessment of liver fibrosis using pharmacokinetic parameters of dynamic contrast-enhanced magnetic resonance imaging[J].J Magn Reson Imaging,2016,44(1):98-104.
|
|
[24]CHEN BB,SHIH TT.DCE-MRI in hepatocellular carcinoma-clinical and therapeutic image biomarker[J].World J Gastroenterol,2014,20(12):3125-3134.
|
|
[25]HWANG J,KIM YK,LEE WJ,et al.Unenhanced magnetic resonance portography using repetitive arterial or vein labeling method at3.0T[J].J Comput Assist Tomogr,2013,37(6):856-861.
|
|
[26]CHEN L,YU RS.Application of Gd-EOB-DTPA enhanced magnetic resonance imaging in liver and gallbladder diseases[J].J Hepatobiliary Surg,2015,27(6):467-473.(in Chinese)陈璐,余日胜.Gd-EOB-DTPA增强磁共振在肝胆疾病中的应用现状[J].肝胆胰外科杂志,2015,27(6):467-473.
|
|
[27]LEE NK,KIM S,LEE JW,et al.Biliary MR imaging with Gd-EOB-DTPA and its clinical applications[J].Radiographics,2009,29(6):1707-1724.
|
|
[28]SMITH AD,VENIERO JC.Gd-EOB-DTPA as a functional MR cholangiography contrast agent:imaging gallbladder filling in patients with and without hepatobiliary dysfunction[J].J Comput Assist Tomogr,2011,35(4):439-445.
|
|
[29]LEE SW,CHA SH,CHUNG HH,et al.Functional magnetic resonance cholangiography with Gd-EOB-DTPA:a study in healthy volunteers[J].Magn Reson Imaging,2014,32(4):385-391.
|
|
[30]YACOUB JH,YOUSUF A,AGRAWAL G,et al.Evaluation of the gallbladder and cystic duct patency with gadoxetate disodium enhanced MR cholangiography:prospective comparison of patients with normal gallbladder function and acute cholecystitis[J].Acta Radiol,2015,56(7):782-789.
|
DownLoad: